HIV/AIDS患者死亡原因研究进展
Research Progress on the Causes of Death in HIV/AIDS Patients
摘要: 艾滋病以免疫破坏为主要表现，曾一度作为我国传染病中死亡率居高的疾病。本文探讨了HIV/AIDS患者的死亡原因及相关因素，包括艾滋病相关死亡与艾滋病无关死亡，并浅谈了针对各类危险因素的预防、控制方法与建议，希望能够提高临床医生对HIV感染者死亡危险因素的认识，并及早做出干预，更有效地延长患者生命。
Abstract: AIDS, mainly characterized by immune destruction, was once a high mortality disease in China. This paper discusses the causes of death and related factors of HIV/AIDS patients, including AIDS-related deaths and non-AIDS-related deaths, and discusses the prevention and control methods and suggestions for various risk factors, hoping to improve clinicians’ understanding of the risk factors of death of HIV infected people, and make early intervention to prolong the life of patients more effectively.
文章引用：苗思涵. HIV/AIDS患者死亡原因研究进展[J]. 临床医学进展, 2025, 15(4): 601-606. https://doi.org/10.12677/acm.2025.154972

参考文献

[1] 中华医学会感染病学分会艾滋病学组, 中国疾病预防控制中心. 中国艾滋病诊疗指南(2024版) [J]. 协和医学杂志, 2024, 15(6): 1261-1288.
[2] UNAIDS (2025) Global HIV & AIDS Statistics—Fact Sheet.
https://www.unaids.org/en/resources/fact-sheet
[3] 2024年第二季度全国艾滋病性病疫情[J]. 中国艾滋病性病, 2024, 30(9): 893.
[4] Zhao, Y., Wei, L., Dou, Z., Zhao, D., Gan, X., Wu, Y., et al. (2023) Changing Mortality and Patterns of Death Causes in HIV Infected Patients—China, 2013-2022. China CDC Weekly, 5, 1073-1078. [Google Scholar] [CrossRef] [PubMed]
[5] 严芝蔓, 林志峰, 黄雪刚, 等. 2005-2022年防城港市艾滋病患者累积死亡率趋势及艾滋病相关和无关死亡危险因素分析[J]. 现代预防医学, 2024, 51(10): 1729-1735, 1765.
[6] 袁风顺, 张灵麟, 何芳, 等. 2013-2022年四川省报告当年即死亡HIV/AIDS患者特征及影响因素分析[J]. 预防医学情报杂志, 2024, 40(9): 1049-1056.
[7] Trickey, A., McGinnis, K., Gill, M.J., Abgrall, S., Berenguer, J., Wyen, C., et al. (2024) Longitudinal Trends in Causes of Death among Adults with HIV on Antiretroviral Therapy in Europe and North America from 1996 to 2020: A Collaboration of Cohort Studies. The Lancet HIV, 11, e176-e185. [Google Scholar] [CrossRef] [PubMed]
[8] Ingle, S.M., May, M.T., Gill, M.J., Mugavero, M.J., Lewden, C., Abgrall, S., et al. (2014) Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy among HIV-Infected Patients. Clinical Infectious Diseases, 59, 287-297. [Google Scholar] [CrossRef] [PubMed]
[9] Nomah, D.K., Jamarkattel, S., Bruguera, A., Moreno-Fornés, S., Díaz, Y., Alonso, L., et al. (2024) Evolving AIDS-and Non-Aids Mortality and Predictors in the PISCIS Cohort of People Living with HIV in Catalonia and the Balearic Islands (Spain), 1998-2020. Open Forum Infectious Diseases, 11, ofae132. [Google Scholar] [CrossRef] [PubMed]
[10] Tang, G., Tong, S., Yuan, X., Lin, Q., Luo, Y., Song, H., et al. (2021) Using Routine Laboratory Markers and Immunological Indicators for Predicting Pneumocystis Jiroveci Pneumonia in Immunocompromised Patients. Frontiers in Immunology, 12, Article 652383. [Google Scholar] [CrossRef] [PubMed]
[11] Ahmadpour, E., Valilou, S., Ghanizadegan, M.A., Seyfi, R., Hosseini, S.A., Hatam-Nahavandi, K., et al. (2024) Global Prevalence, Mortality, and Main Characteristics of Hiv-Associated Pneumocystosis: A Systematic Review and Meta-Analysis. PLOS ONE, 19, e0297619. [Google Scholar] [CrossRef] [PubMed]
[12] Feng, Q., Hao, J., Li, A. and Tong, Z. (2022) Nomograms for Death from Pneumocystis Jirovecii Pneumonia in HIV-Uninfected and HIV-Infected Patients. International Journal of General Medicine, 15, 3055-3067. [Google Scholar] [CrossRef] [PubMed]
[13] Huang, L., Cattamanchi, A., Davis, J.L., Boon, S.d., Kovacs, J., Meshnick, S., et al. (2011) HIV-Associated Pneumocystis Pneumonia. Proceedings of the American Thoracic Society, 8, 294-300. [Google Scholar] [CrossRef] [PubMed]
[14] 石慧鑫, 蒋梦媛, 邵煜涵, 等. 耶氏肺孢子菌肺炎研究进展[J]. 中国真菌学杂志, 2024, 19(2): 206-210.
[15] Trickey, A., May, M.T., Gill, M.J., Grabar, S., Vehreschild, J., Wit, F.W.N.M., et al. (2020) Cause‐Specific Mortality after Diagnosis of Cancer among HIV‐Positive Patients: A Collaborative Analysis of Cohort Studies. International Journal of Cancer, 146, 3134-3146. [Google Scholar] [CrossRef] [PubMed]
[16] Mosam, A., Aboobaker, J. and Shaik, F. (2010) Kaposiʼs Sarcoma in Sub-Saharan Africa: A Current Perspective. Current Opinion in Infectious Diseases, 23, 119-123. [Google Scholar] [CrossRef] [PubMed]
[17] Park, L.S., Hernández-Ramírez, R.U., Silverberg, M.J., Crothers, K. and Dubrow, R. (2016) Prevalence of Non-HIV Cancer Risk Factors in Persons Living with HIV/Aids. AIDS, 30, 273-291. [Google Scholar] [CrossRef] [PubMed]
[18] 罗琳琳, 姜琦, 胡新宁, 等. 艾滋病合并恶性肿瘤研究进展[J]. 中华医院感染学杂志, 2024, 34(17): 2715-2720.
[19] 李露, 罗春香, 董超. 艾滋病相关肿瘤的研究进展[J]. 中国临床医生杂志, 2018, 46(2): 140-143.
[20] Pu, J. and Wu, J. (2024) Survival Analysis of PLWHA Undergoing Combined Antiretroviral Therapy: Exploring Long-Term Prognosis and Influencing Factors. Frontiers in Public Health, 12, Article 1327264. [Google Scholar] [CrossRef] [PubMed]
[21] 宋怡宁, 李亚君, 孙秀彬, 等. 2013-2022年山东省HIV/AIDS患者死亡趋势及影响因素分析[J]. 现代预防医学, 2024, 51(4): 589-594, 612.
[22] 姚书杰, 周金玲, 王莉, 等. 辽宁省艾滋病抗病毒治疗死亡患者生存时间及相关因素分析[J]. 中国公共卫生, 2016, 32(12): 1633-1637.
[23] 孙若寒, 金艳涛, 康秋佳, 等. 运用限制性立方样条分析老年HIV/AIDS患者CD4+T淋巴细胞计数与死亡的剂量-反应关系[J]. 中国皮肤性病学杂志, 2025, 39(1): 81-87.
[24] 田彩虹, 秦小佳, 张军, 等. 2013-2023年广安市HIV感染者及AIDS患者死亡病例分析[J]. 中国麻风皮肤病杂志, 2025, 41(1): 23-28.
[25] 兰慧, 庞轶, 李旭丹, 等. 成都市锦江区2012-2022年艾滋病抗病毒治疗患者生存情况分析[J]. 现代预防医学, 2024, 51(8): 1518-1523.
[26] 王实, 陈方方, 金怡晨, 等. 2004-2021年我国HIV阳性MSM超额死亡率及其影响因素分析[J]. 中国艾滋病性病, 2024, 30(5): 475-480.
[27] So-Armah, K., Benjamin, L.A., Bloomfield, G.S., Feinstein, M.J., Hsue, P., Njuguna, B., et al. (2020) HIV and Cardiovascular Disease. The Lancet HIV, 7, e279-e293. [Google Scholar] [CrossRef] [PubMed]
[28] So-Armah, K. and Freiberg, M.S. (2018) HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations, and Novel Biomarkers. Current HIV/AIDS Reports, 15, 233-244. [Google Scholar] [CrossRef] [PubMed]
[29] Feinstein, M.J., Hsue, P.Y., Benjamin, L.A., Bloomfield, G.S., Currier, J.S., Freiberg, M.S., et al. (2019) Characteristics, Prevention, and Management of Cardiovascular Disease in People Living with HIV: A Scientific Statement from the American Heart Association. Circulation, 140, e98-e124. [Google Scholar] [CrossRef] [PubMed]
[30] Paternò Raddusa, M.S., Marino, A., Celesia, B.M., Spampinato, S., Giarratana, C., Venanzi Rullo, E., et al. (2024) Atherosclerosis and Cardiovascular Complications in People Living with HIV: A Focused Review. Infectious Disease Reports, 16, 846-863. [Google Scholar] [CrossRef] [PubMed]
[31] Jiang, H., Xie, N., Cao, B., Tan, L., Fan, Y., Zhang, F., et al. (2013) Determinants of Progression to AIDS and Death Following HIV Diagnosis: A Retrospective Cohort Study in Wuhan, China. PLOS ONE, 8, e83078. [Google Scholar] [CrossRef] [PubMed]
[32] 张莹, 张培栋, 周志伟, 等. 2008-2022年徐州市艾滋病发病及死亡趋势分析[J]. 东南大学学报(医学版), 2024, 43(1): 104-110.
[33] 谢年华, 闫晗, 马红飞, 等. 武汉市1994~2022年HIV感染者/AIDS患者的生存时间及其影响因素[J]. 华中科技大学学报(医学版), 2024, 53(5): 641-646.
[34] 田波, 金永梅, 李重熙, 等. 艾滋病抗病毒治疗患者心血管风险评估及影响因素分析[J]. 中国艾滋病性病, 2023, 29(12): 1290-1294.
[35] 宋亮, 丁海峰, 于淼, 等. 北京市朝阳区老年HIV感染者和AIDS患者生存状况分析[J]. 中国预防医学杂志, 2024, 25(2): 173-179.
[36] 马琳, 吴小雪, 张亚丽, 等. 某省中老年HIV/AIDS患者特征及发现12个月内治疗死亡情况分析[J]. 现代预防医学, 2024, 51(11): 1933-1937, 1955.
[37] 陆雪倩, 孙文秀, 潘燕云, 等. 老年HIV感染者心理痛苦现状及影响因素研究[J]. 中华护理杂志, 2024, 59(22): 2747-2753.
[38] 朱勇, 刘代强, 谢加伟, 等. 1984例HIV/AIDS患者抗病毒治疗后的死亡影响因素及列线图预测模型的构建[J]. 中国国境卫生检疫杂志, 2024, 47(6): 636-641.
[39] 张景慧. 延安市394例COVID-19住院患者病例分析[D]: [硕士学位论文]. 延安: 延安大学, 2024.
[40] 国家卫生健康委, 国家中医药局. 新型冠状病毒感染诊疗方案(试行第十版) [J]. 传染病信息, 2023, 36(1): 18-25.
[41] 莫初叶, 康旖雯, 张君涵, 等. HIV与COVID-19共感染患者死亡和重症风险的meta分析[J]. 热带医学杂志, 2024, 24(2): 207-213.
[42] 袁清青, 李芙蓉, 阮艺宏, 等. 中国艾滋病患者群体中抑郁症患病率Meta分析[J]. 中国艾滋病性病, 2021, 27(1): 45-49.
[43] 谭慧莹, 赵丽红, 唐柳英, 等. 人类免疫缺陷病毒感染者抑郁情绪的危害及其影响因素研究进展[J]. 中国医药导报, 2024, 21(26): 75-79.

为你推荐